Laryngeal findings in users of combination corticosteroid and bronchodilator therapy

Laryngoscope

Volumn 114, Issue 9 I, 2004, Pages 1566-1569

  Mirza, Natasha ^a   Schwartz, Sandra Kasper ^a   Antin Ozerkis, Danielle ^b  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; PROTON PUMP INHIBITOR;

ADULT; AGED; ASTHMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG FORMULATION; DRY POWDER; DYSPHONIA; FEMALE; GASTROINTESTINAL REFLUX; HUMAN; HUMAN TISSUE; HYPEREMIA; LARYNX DISORDER; MAINTENANCE THERAPY; MALE; POWDER INHALER; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY; REVIEW; STROBOSCOPY; VOCAL CORD; VOICE;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ADULT; AGED; AGED, 80 AND OVER; ALBUTEROL; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; DILATATION, PATHOLOGIC; DRUG THERAPY, COMBINATION; FEMALE; HEMORRHAGE; HUMANS; LARYNGEAL DISEASES; LARYNGEAL EDEMA; LARYNGEAL NEOPLASMS; LARYNGITIS; LARYNGOSCOPY; LARYNX; LEUKOPLAKIA; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; VOCAL CORDS; VOICE DISORDERS;

EID: 4644236347     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200409000-00012     Document Type: Review

References (14)

1. Nelson HS. Advair: combination treatment with fluticasone propionate/salmeterol in the treatment of asthma. J Allergy Clin Immunol 2001;107:398-416.
2. National Asthma Education and Prevention Program. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report II. NIH publication No. 97-4051. Bethesda, MD: National Institutes of Health, National Heart, Lung, and Blood Institute, 1997.
3. Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000;106:1088-1095.
4. Markham A, Jarvis B. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Drugs 2000;60:1207-1233.
5. Babu S, Samuel P. The effect of inhaled steroids on the upper respiratory tract. J Laryngol Otol 1988;102:592-594.
6. Henry RL. Inhaled corticosteroid agents and dysphonia. Med J Aust 1987;147:365.
7. Gemci T, Corcoran TE, Chigier N. Dispersion and deposition of inhalation therapy sprays in the larynx and trachea using experimental and numerical methods. Presented at the Eighth International Conference on Liquid Atomization and Spray Systems, Pasadena, CA, 2000.
8. Corcoran TE, Chigier N. Characterization of the laryngeal jet using phase Doppler interferometry. J Aerosol Med 2000;13:125-137.
9. Malley TR, De Miguel I, Patel N, et al. In-vitro performance of Advair Diskus at low inspiratory flow rates. Presented at the American Thoracic Society 98th International Conference, Atlanta, GA, May 1992.
10. Gustafsson P, Johal B, Burnell PK, et al. total and fine drug particle mass generated from two dry powder inhalers by children with asthma aged 4 and 8 years [abstract]. Am J Respir Crit Care Med 2003;167:A271.
11. Willaimson IJ, Matusiewicz SP, Brown PH, et al. Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations. Eur Respir J 1995;8:590-592.
12. Kumazawa H, Asako M, Yamashita T, Ha-Kawa SK. An increase in laryngeal aerosol deposition by ultrasonic nebulizer therapy with intermittent vocalization. Laryngoscope 1997;107:671-674.
13. Grant D. A caution in the use of laryngeal sprays. 1898. J Laryngol Otol 1998;112:506.
14. Dubus JC, Marguet C, Deschildre A, et al, for the Reseau de Recherche Clinique en Pneumonologie Pediatrique. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy 2001;56:944-948.